<?xml version="1.0"?>

<document>
	<title>Kappa-chain deficiency.  An immunoglobulin disorder.</title>

	<author>Zegers-B-J.</author>
	<author>Maertzdorf-W-J.</author>
	<author>Van-Loghem-E.</author>
	<author>Mul-N-A.</author>
	<author>Stoop-J-W.</author>
	<author>Van-Der-Laag-J.</author>
	<author>Vossen-J-J.</author>
	<author>Ballieux-R-E.</author>

	<source>N-Engl-J-Med. 1976 May 6. 294(19). P 1026-30.</source>

	<abstract>Since kappa-chain deficiency is an unusual condition, we studied the
   clinical and laboratory findings in a patient with this deficiency.
   The patient had cystic fibrosis with concurrent malabsorption,
   diabetes mellitus and IgA deficiency. The serum levels of IgM and IgG
   were 0.85 and 7.22 mg per milliliter, respectively. Kappa type IgM
   and IgG was not present in serum and external secretions; gamma, mu
   and lambda chains were probably polyclonal in character. Antibodies
   against kappa chains were not detected in either the patient or the
   mother. Plasma cells containing kappa-type immunoglobulins were
   absent in jejunum samples and bone marrow; kappa-chainbearing B
   lymphocytes could not be detected in blood and bone marrow. The serum
   of one of the patient&apos;s sisters contained trace amounts of kappa-type
   immunoglobulins. The patient displays a complete absence of kappa-
   type immunoglobulins, probably owing to a genetic defect.</abstract>

	<majorsubject>ANTI-ANTIBODIES: an</majorsubject>
	<majorsubject>DYSGAMMAGLOBULINEMIA: im</majorsubject>
	<majorsubject>IGA: an</majorsubject>
	<majorsubject>IMMUNOGLOBULINS-KAPPA-CHAIN</majorsubject>
	<majorsubject>IMMUNOGLOBULINS-LIGHT-CHAIN</majorsubject>
	<majorsubject>IMMUNOLOGIC-DEFICIENCY-SYNDROMES: im</majorsubject>

	<minorsubject>ANTIBODY-FORMATION</minorsubject>
	<minorsubject>ANTIBODY-SPECIFICITY</minorsubject>
	<minorsubject>CHILD-PRESCHOOL</minorsubject>
	<minorsubject>CYSTIC-FIBROSIS: co, fg, im</minorsubject>
	<minorsubject>DIABETES-MELLITUS-INSULIN-DEPENDENT:  co</minorsubject>
	<minorsubject>DYSGAMMAGLOBULINEMIA: co, fg</minorsubject>
	<minorsubject>HUMAN</minorsubject>
	<minorsubject>IGG: ip</minorsubject>
	<minorsubject>IGM: ip</minorsubject>
	<minorsubject>IMMUNOELECTROPHORESIS</minorsubject>
	<minorsubject>LINKAGE-GENETICS</minorsubject>
	<minorsubject>MALABSORPTION-SYNDROMES:  co</minorsubject>
	<minorsubject>MALE</minorsubject>
	<minorsubject>PHENOTYPE</minorsubject>

	<reference>001   HOBBS JR              ADV CLIN CHEM                   14   219 971</reference>
	<reference>002   NATVIG JB             ADV IMMUNOL                     16    59 973</reference>
	<reference>003?  SELIGMANN M           REV FR ETUD CLIN BIOL           12   604 967</reference>
	<reference>004   BERNIER GM            BLOOD                           40   795 972</reference>
	<reference>005   BARANDUN S            BLOOD                           47    79 976</reference>
	<reference>007   MAERTZDORF W          EUR J CLIN INVEST                2   294 972</reference>
	<reference>008   VAN DER GIESSEN M     CLIN EXP IMMUNOL                21   501 975</reference>
	<reference>009   VAN LOGHEM E          IN: WEIR DM                            1 973</reference>
	<reference>010   MUL NAJ               EUR J CLIN INVEST                5    63 975</reference>
	<reference>011   HIJMANS W             CLIN EXP IMMUNOL                 4   457 969</reference>
	<reference>012   VOSSEN JM             ANN NY ACAD SCI                254   262 975</reference>
	<reference>013   HIJMANS W             IN: PEETERS H                        181 973</reference>
	<reference>014   ROSAN RC              AM J DIS CHILD                 104   625 962</reference>
	<reference>015   PENNY R               J PEDIATR                       78   512 971</reference>
	<reference>016   VYAS GN               CLIN GENET                       1    45 970</reference>
	<reference>017   NADORP JHS            EUR J CLIN INVEST                3   317 973</reference>
	<reference>018   BALLIEUX RE           ADV EXP MED BIOL                45   423 973</reference>
	<reference>019   LAWTON AR             CONTEMP TOP IMMUNOBIOL           3   193 974</reference>
	<reference>020   VAN LOGHEM E          EUR J IMMUNOL                    4    57 974</reference>
	<reference>021   HOOD L                IN: STERZL J                         283 970</reference>
	<reference>022   NUSSENZWEIG V         J EXP MED                      126   727 967</reference>
	<reference>023   CAPRA JD              PROC NAT ACAD SCI USA           69    40 972</reference>
	<reference>024   FRANKLIN EC           J IMMUNOL                      107  1527 971</reference>

	<citation>1   SOLOMON A             SCAND J IMMUNOL                  5   685 976</citation>
	<citation>2   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977</citation>
	<citation>3   VANTHIEL DH           ANN INTERN MED                  86    10 977</citation>
	<citation>4   COIFFIER B            LYON MED                       237   399 977</citation>
	<citation>5   COOPER MD             SPRINGER SEMIN IMMUNOPATHOL      1   265 978</citation>
	<citation>6   SMITH WI              DIABETES                        27  1092 978</citation>
	<citation>7   HENDRICKX GFM         ACTA PAEDIATR SCAND             68   187 979</citation>
	<citation>8   MILLER ME             AM J HEMATOL                     8   333 980</citation>
	<citation>9   HODDINOTT S           DIABETOLOGIA                    23   326 982</citation>
	<citation>10   VANLOGHEM E           J CLIN INVEST                   72  1918 983</citation>
	<citation>11   ROSEN FS              N ENGL J MED                   311   300 984</citation>
	<citation>12   WEDGWOOD RJ           CLIN IMMUNOL ALLERGY             5   301 985</citation>
	<citation>13   STAVNEZER J           NUCLEIC ACIDS RES               13  3495 985</citation>
	<citation>14   STAVNEZERNORDGREN J   SCIENCE                        230   458 985</citation>
	<citation>15   OLIVIERO S            J IMMUNOGENET                   13     3 986</citation>
	<citation>16   MOSS RB               MONOGR ALLERGY                  19   202 986</citation>
	<citation>17   MONTECUCCO C          ARTHRITIS RHEUM                 29  1532 986</citation>
	<citation>18   RENCKENS ALJM         CLIN CHEM                       32  2147 986</citation>
	<citation>19   BUCKLEY RH            CLIN IMMUNOL IMMUNOPATHOL       40    13 986</citation>
	<citation>20   MONTECUCCO C          HAEMATOLOGICA                   71   237 986</citation>

</document>
